Medicine and Dentistry
Heart Right Ventricle Failure
100%
Acute Pulmonary Embolism
89%
Pulmonary Embolism
81%
Pulmonary Hypertension
48%
Right Ventricular Hypertrophy
43%
Chronic Thromboembolic Pulmonary Hypertension
42%
Right Ventricular Function
38%
Right Ventricle
37%
Hemodynamic
33%
Levosimendan
26%
Lung Vascular Resistance
26%
Lung Artery Pressure
25%
Heart Output
25%
Endarterectomy
24%
Sildenafil
23%
Afterload
22%
Systolic Blood Pressure
21%
Pulmonary Artery
16%
Stroke Volume
15%
Echocardiography
15%
Patent Foramen Ovale
14%
Blood Clot Lysis
14%
Inotropism
13%
Heart Function
13%
Artificial Respiration
13%
Transesophageal Echocardiography
12%
Cardiovascular System
11%
Nitric Oxide
11%
Semaxanib
11%
Congestive Heart Failure
10%
Pulmonary Embolism Response Team
10%
Apoplexy
10%
Magnetic Resonance Imaging
10%
Heart Ventricle Remodeling
10%
Heart Ventricle Pressure
9%
Angioplasty
9%
Fibrosis
9%
Heart Right Ventricle Function
9%
Persistent Truncus Arteriosus
9%
Brain Ischemia
9%
Atrial Fibrillation
9%
Hypoxia
9%
Vasodilatation
9%
Peripheral Vasodilating Agent
8%
Out of Hospital Cardiac Arrest
8%
Dobutamine
8%
Prostacyclin
8%
Phosphodiesterase V
8%
Thrombectomy
8%
Ketone Bodies
8%
Keyphrases
Acute Pulmonary Embolism
67%
Right Ventricular Function
61%
Pulmonary Embolism
45%
Right Ventricular
38%
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
38%
Pulmonary Artery Banding
33%
Pressure Overload
28%
Porcine Model
23%
Right Heart Failure
22%
Levosimendan
22%
Right Ventricular Hypertrophy
21%
Pulmonary Vascular Resistance
21%
Pulmonary Endarterectomy
20%
Pulmonary Arterial Hypertension
19%
Right Ventricle
18%
Mean Pulmonary Artery Pressure (mPAP)
16%
Sildenafil
14%
Cardiac Output
13%
Pulmonary Hypertension
13%
Sham
13%
Intermediate-risk Pulmonary Embolism
12%
Stroke Volume
12%
High-risk Pulmonary Embolism
12%
Right Heart
11%
Patent Foramen Ovale
10%
Patent Foramen Ovale Closure
10%
Biventricular
10%
Cardiac Function
10%
Pressure-volume Loop
9%
Denmark
9%
Pulmonary Artery Systolic Pressure
9%
Echocardiography
9%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
8%
Exhaled Nitric Oxide
8%
Riociguat
8%
Hypertension Patients
8%
Transesophageal Echocardiography
8%
Heart Failure
8%
Right Ventricular Afterload
8%
Intermediate Risk
7%
Pulmonary Vasodilators
7%
Pulmonary Artery
7%
Right Ventricular Remodeling
7%
Atrial Fibrillation
7%
Pressure-volume
7%
Echocardiographic
6%
Sugen 5416
6%
Treprostinil
6%
Right Heart Hemodynamics
5%
Cardiopulmonary Hemodynamics
5%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Right Ventricle Failure
63%
Pulmonary Hypertension
52%
Chronic Thromboembolic Pulmonary Hypertension
46%
Lung Embolism
44%
Heart Right Ventricle Hypertrophy
22%
Porcine Model
19%
Sildenafil
14%
Patent Foramen Ovale
13%
Levosimendan
13%
Cerebrovascular Accident
12%
Biological Marker
12%
Semaxanib
11%
Heart Ventricle Remodeling
10%
Phosphodiesterase V
9%
Brain Ischemia
9%
Wistar Rat
9%
Hypoxia
9%
Fibrosis
8%
Prostacyclin
8%
Venous Thromboembolism
8%
Infarction
7%
Congestive Heart Failure
7%
Peripheral Vasodilating Agent
6%
Ischemia
6%
Mortality Rate
6%
Cohort Study
6%
Obstruction
5%
Guanylate Cyclase
5%
Heart Ventricle Hypertrophy
5%
Cyclic GMP
5%
Treprostinil
5%